Experts say the bipartisan Break Up Big Medicine Act — aimed at breaking up vertically integrated healthcare companies — faces slim chances of passing despite recent PBM reforms.
The dispute reflects broader pressures on payers and providers, with rising costs and administrative inefficiencies driving contentious contract battles and highlighting the need for deeper cost-control innovation.
Its new features transform how you can track and analyze the more than 200,000 bills, regulations, and other measures set to be introduced this year.
If Moderna's full financial payout to the companies is reached, it would rank among the largest disclosed patent settlements in biopharmaceutical industry history.
The case highlights ongoing questions about governance and standards for national health data sharing, with Health Gorilla arguing the dispute should be handled through interoperability networks’ internal processes rather than in federal court.
The case highlights federal and state scrutiny of hospital consolidation and restrictive contracting practices — with potential implications for payers, patients and healthcare markets across the country.
During a panel at ViVE in Los Angeles, healthcare leaders outlined how access to care underpins the economic stability of rural America.
Experts say Hims & Hers’ acquisition of Eucalyptus positions the company for global expansion and revenue diversification amid U.S. GLP-1 regulatory challenges.
Let's cut through the confusion and focus on what actually matters for your planning.
They argue automation is not just about efficiency, but also a practical and necessary solution to workforce shortages and system inefficiencies.
The FDA’s refuse-to-file letter cited no safety or efficacy concerns. The company said the agency’s justification for refusing a review is inconsistent with guidance given prior to the start of Phase 3 testing.
Legal teams ask a practical question. If large language models are so capable, why does legal AI still depend on curated content, and why does surfacing that content matter so much?
The Consolidated Appropriations Act of 2026 and the Department of Labor’s proposed rule implement major PBM reforms for employers, but don’t include everything they want, including a ban on spread pricing.
HHS is scrapping its proposed 340B rebate pilot after hospitals sued to stop it. Providers say the plan would have created cash flow problems and administrative burdens that threatened safety-net care.
Digital health is entering a more mature phase in 2026 as consolidation accelerates through targeted M&A, driven by the need for scale, artificial intelligence and pressure from payers, investors say.
Included Health is launching an alternative health plan centered on primary care, AI support, price transparency, and easier navigation.
Across all industries, the total number of companies on track to go public could make this week the most active for IPOs since 2021. Despite the partial government shutdown, there are paths biotechs can pursue to the public markets.